T. Meijer

Ex vivo tumor culture systems for functional drug testing and therapy response prediction

A. Jager, D. V. van Gent, T. Meijer, 2017, Future science OA.

Functional Ex Vivo Assay Reveals Homologous Recombination Deficiency in Breast Cancer Beyond BRCA Gene Defects

A. Sieuwerts, M. Smid, J. Martens, 2018, Clinical Cancer Research.

Functional RECAP (REpair CAPacity) assay identifies homologous recombination deficiency undetected by DNA-based BRCAness tests

A. Sieuwerts, H. Davies, S. Nik-Zainal, 2022, Oncogene.

Functional RECAP (REpair CAPacity) assay identifies homologous recombination deficiency undetected by DNA-based BRCAness tests

A. Sieuwerts, H. Davies, S. Nik-Zainal, 2022, Oncogene.

Direct Ex Vivo Observation of Homologous Recombination Defect Reversal After DNA-Damaging Chemotherapy in Patients With Metastatic Breast Cancer.

A. Jager, W. Dinjens, C. V. van Deurzen, 2019, JCO precision oncology.

Identification of novel determinants of resistance to lapatinib in ERBB2-amplified cancers

A. Ashworth, J. Reis-Filho, D. Cunningham, 2014, Oncogene.

Functional Ex Vivo Tissue-Based Chemotherapy Sensitivity Testing for Breast Cancer

A. Jager, C. V. van Deurzen, M. D. den Bakker, 2022, Cancers.

Ex vivo treatment of prostate tumor tissue recapitulates in vivo therapy response

Edgar Schönfeld, R. Kanaar, D. V. van Gent, 2018, The Prostate.

Validation and development of MTH1 inhibitors for treatment of cancer.

Y. Kallberg, P. Artursson, R. Zubarev, 2016, Annals of oncology : official journal of the European Society for Medical Oncology.

Down-staging (

Different effort constructs and effort-reward imbalance: effects on employee well-being in ancillary health care workers.

J. Hamers, J. de Jonge, T. Meijer, 2001, Journal of advanced nursing.